Industry Overview
Ephedrine is a sympathomimetic amine and medication used primarily for the prevention and treatment of hypotension, particularly during spinal anesthesia. It has also been used for asthma, narcolepsy, obesity, allergic conditions, and as an adjunct to neostigmine in the treatment of myasthenia gravis. Ephedrine may be administered orally or by subcutaneous, intramuscular, or intravenous injection, while topical applications are also used for respiratory and conjunctival mucosa.
Ephedrine was first isolated in 1885 and entered commercial use in 1926. It is naturally obtained from plants of the Ephedra genus, with Ma Huang, a mixture of E. equisetina, E. sinica, and E. distachya, identified in the report as a preferred natural source. The crude alkaloid yield is reported at 0.5–2%, depending on species, with up to 90% potentially being ephedrine. Ephedrine sulphate and hydrochloride are used for systemic applications.
The report covers the properties, chemistry, medical and other uses, market position, Indian pharmaceutical and API industry, import and export data, opportunities and challenges, patents, production schemes, manufacturing processes, isolation and crystallization, plant layout, and suppliers. It also examines chemical synthesis, extraction, biosynthetic approaches, ephedrine hydrochloride, pseudoephedrine, and the associated plant economics.
Cost Estimation
| Particulars | Value |
|---|---|
| Plant Capacity | 5.00 TON/day |
| Land & Building (3000 sq.mt.) | Rs. 4.00 Cr |
| Plant & Machinery | Rs. 3.09 Cr |
| Working Capital for 2 Months | Rs. 17.52 Cr |
| Total Capital Investment | Rs. 24.93 Cr |
| Rate of Return | 42% |
| Break Even Point | 34% |
Content Index
- INTRODUCTION
- PROPERTIES OF EPHEDRINE
- PROPERTIES OF EPHEDRINE HYDROCHLORIDE
- CLASSIFICATION (FORMS)
- NOMENCLATURE
- GRADES
- MECHANISM OF ACTION
- COMPOUNDS WITH DECREASING Α-RECEPTOR AFFINITY
- MEDICAL USE
- OTHER USES
- USES AND APPLICATIONS
- CHEMISTRY AND NOMENCLATURE OF EPHEDRINE
- CONTRAINDICATION AND ADVERSE EFFECTS OF EPHEDRINE
- ADVERSE EFFECTS
- STRUCTURE OF EPHEDRINES
- FIGURE: FREUDENBERG AND LEITHE REPRESENTATION OF EPHEDRINE 1A AND PSEUDOEPHEDRINE 2A.
- FIGURE. STABLE CONFORMATIONS OF EPHEDRINE 1B AND PSEUDOEPHEDRINE
- FIGURE. EPHEDRINE STEREOISOMERS.
- FIGURE: NOREPHEDRINE STEREOISOMERS.
- PHYSICAL PROPERTIES OF EPHEDRINES
- MARKET SURVEY AND GROWTH ASPIRATION OF INDIAN PHARMACEUTICAL INDUSTRY
- OPPORTUNITIES AND CHALLENGES FOR ACHIEVING VISION 2030
- OPPORTUNITIES
- EXHIBIT 3
- PATENT ANALYSIS
- A FOOTPRINT IN UNDERPENETRATED INTERNATIONAL MARKETS COULD INCREASE EXPORTS
- LEVERAGE INDIA'S STRENGTHS IN IT AND ITES – OPTIMIZE NEW AVENUES SUCH AS OTC
- CHALLENGES
- INDIA IS YET TO ACHIEVE UNIVERSAL HEALTHCARE ACCESS
- LACK OF A STABLE PRICING AND POLICY ENVIRONMENT FAVOURABLE FOR LONG-TERM INVESTMENT DECISIONS
- LACK OF CAPABILITIES IN THE INNOVATION SPACE
- DEPENDENCE ON EXTERNAL MARKETS FOR INTERMEDIATES AND APIS
- INDIAN PHARMA’S ERODING COMPETITIVE ADVANTAGE IN THE US GENERICS MARKET & LIMITED PRESENCE IN OTHER MARKETS AND PRODUCTS
- INCREASED SCRUTINY IN QUALITY COMPLIANCE WHEN SUPPLYING TO INTERNATIONAL MARKETS
- OVERVIEW OF INDIAN PHARMACEUTICAL INDUSTRY
- IMPORT DATA OF EPHEDRINE
- EXPORT DATA OF EPHEDRINE
- MARKET POSITION OF API (ACTIVE PHARMA INGREDIENT)
- INDIA API MARKET TRADE (%), FY 2016
- SHARE OF INDIA IN GLOBAL API MARKET (%), FY 2016
- SHARE OF INDIA IN GLOBAL API MARKET
- INDIAN API DOMESTIC CONSUMPTION MARKET FUTURE OUTLOOK
- INDIAN API DOMESTIC CONSUMPTION MARKET (BILLION US$), FY 2015-FY 2022
- MAJOR APIS IN THE INDIAN API MARKET
- MAJOR APIS IN THE INDIAN API MARKET
- DRIVERS
- RISING HEALTHCARE EXPENDITURE
- HEALTHCARE EXPENDITURE (US$ PER HEAD), 2012-2016
- INCREASING DISPOSABLE INCOMES
- PERSONAL DISPOSABLE INCOME (TRILLION US$), 2012-2016
- GROWING GERIATRIC POPULATION
- INDIAN POPULATION - 60 YEARS OR ABOVE (MILLION), 2015 & 2030
- INCREASING INCIDENCES OF CHRONIC DISEASES
- CARDIOVASCULAR DISEASES
- DIABETES
- INDIA - NUMBER OF PEOPLE WITH DIABETES (MILLION), 2015 & 2040
- PATENT EXPIRY OF BLOCKBUSTER DRUGS
- LIST OF BLOCKBUSTER DRUGS LOSING PATENT (2016-2022)
- INCREASED CONSUMPTION OF GENERIC DRUGS
- INVENTION OF NEW GENERATION OF APIS
- CHALLENGES
- OVER DEPENDENCE ON CHINA FOR IMPORTS
- API IMPORT FROM CHINA (BILLION US$), FY 2012 TO FY 2015
- THE REASONS FOR LOW MANUFACTURING COST OF API IN CHINA ARE:
- GLOBAL MARKET POSITION OF EPHEDRINE
- PRODUCTION SCHEMES OF EPHEDRINE
- PRODUCTION SCHEMES OF EPHEDRINE
- (1) EXTRACTION FROM EPHEDRA PLANTS
- (2) FERMENTATION OF SUGAR FOLLOWED BY AMINATION
- (3) CHEMICAL SYNTHESIS: BROMINATION OF PROPIOPHENONE FOLLOWED BY AMINATION
- PROCESS OF MANUFACTURE
- MANUFACTURING PROCESS:-
- REACTION WITH ACTIVELY FERMENTING GLUCOSE SOLUTION:-
- CONDENSATION WITH METHYLAMINE:-
- REDUCTION TO PRODUCE 1-EPHEDRINE:-
- CONVERSION TO EPHEDRINE HYDROCHLORIDE:-
- PACKING AND FORWARDING:-
- PROCESS FLOW SHEET FOR THE MANUFACTURE OF EPHEDRINE HYDROCHLORIDE (KETOL)
- BIOSYNTHETICS OF EPHEDRINE (ORGANIC)
- OTHER METHODS:
- PREPARATION OF PROPIONYL CHLORIDE AND PROPIOPHENONE
- EPHEDRONE [Α-METHYLAMINOETHYL PHENYL KETONE]
- DL -EPHEDRINE HYDROCHLORIDE
- SYNTHESIS
- ANOTHER METHOD:
- DL -EPHEDRINE HYDROCHLORIDE
- METHOD FOR MANUFACTURING EPHEDRINE OR PSEUDOEPHEDRINE
- METHYLAMINE SOLUTION PREPARING THESE SOLVENTS, THERE ARE TWO WAYS:
- MANUFACTURING PROCESS OF PSEUDO EPHEDRINE HCL
- THE PROCESSING STAGES ARE AS FOLLOWS:-
- STAGE-1
- STAGE-2
- STAGE-3
- STAGE-4
- PROCESS FLOW DIAGRAM
- INNOVATION TWO STAGE PROCESS FOR THE MANUFACTURE OF EPHEDRINE
- STAGE 1
- STAGE 2
- EPHEDRINE AND ITS SALTS ISOLATION AND PROPERTIES
- EXPERIMENTAL
- EXTRACTION
- PREPARATION OF EPHEDRINE HCL BY FRACTIONAL CRYSTALLIZATION
- SEPARATION OF THE OXALATES BY DIFFERENCE OF SOLUBILITY
- PREPARATION OF PURE EPHEDRINE BASE
- PROPERTIES OF PURE EPHEDRINE
- PSEUDOEPHEDRINE
- ACTION OF HCL UPON EPHEDRINE. PREPARATION OF PSEUDOEPHEDRINE.
- THE MODELING AND 3D STRUCTURES OF EPHEDRINE HYDROCHLORIDE
- RAMAN SPECTRUM OF EPHEDRINE HYDROCHLORIDE
- PLANT LAYOUT
- SUPPLIERS OF RAW MATERIALS
- SUPPLIERS OF PLANT & MACHINERY
Appendix
- APPENDIX – A:
- 01. PLANT ECONOMICS
- 02. LAND & BUILDING
- 03. PLANT AND MACHINERY
- 04. OTHER FIXED ASSESTS
- 05. FIXED CAPITAL
- 06. RAW MATERIAL
- 07. SALARY AND WAGES
- 08. UTILITIES AND OVERHEADS
- 09. TOTAL WORKING CAPITAL
- 10. TOTAL CAPITAL INVESTMENT
- 11. COST OF PRODUCTION
- 12. TURN OVER/ANNUM
- 13. BREAK EVEN POINT
- 14. RESOURCES FOR FINANCE
- 15. INSTALMENT PAYABLE IN 5 YEARS
- 16. DEPRECIATION CHART FOR 5 YEARS
- 17. PROFIT ANALYSIS FOR 5 YEARS
- 18. PROJECTED BALANCE SHEET FOR (5 YEARS)
Frequently Asked Questions
Ephedrine is primarily used as a sympathomimetic medicine for preventing and treating hypotension.
It is particularly associated with the management of low blood pressure during spinal anesthesia. The report also describes applications involving asthma, allergic conditions, central nervous system stimulation, and use as an adjunct to neostigmine in myasthenia gravis. Depending on the formulation and intended application, ephedrine may be administered orally, by injection, or through topical preparations.
Ephedrine occurs naturally in plants belonging to the Ephedra genus.
The report identifies Ma Huang as a preferred natural source and describes it as a mixture of E. equisetina, E. sinica, and E. distachya. It states that crude alkaloid yield varies according to species and that ephedrine can constitute a substantial proportion of the recovered alkaloids. Natural-source processing generally involves extraction and subsequent separation and purification steps to obtain the desired alkaloid or its salt.
Ephedrine hydrochloride is the hydrochloride salt form of ephedrine used in pharmaceutical applications.
The report discusses ephedrine hydrochloride in relation to its properties, preparation, crystallization, structural characterization, and pharmaceutical applications. Salt formation is an important pharmaceutical processing step because the physical and handling properties of an active compound can differ between the free base and its salt forms. Manufacturing and handling of ephedrine hydrochloride require appropriate pharmaceutical controls, quality specifications, and compliance with applicable regulations.
The report discusses natural extraction, fermentation-based approaches, and chemical synthesis as broad production routes for ephedrine.
It covers extraction from Ephedra plants, fermentation-related methods, chemical synthesis, ephedrine hydrochloride production, biosynthetic approaches, and alternative manufacturing methods. It also addresses processing stages, purification, isolation, crystallization, process flow information, and plant layout. Commercial pharmaceutical production requires controlled processes, validated equipment, appropriate quality testing, and compliance with applicable requirements for active pharmaceutical ingredients and controlled substances.
An ephedrine manufacturing project requires careful consideration of raw materials, process technology, plant design, quality systems, safety, and regulatory compliance.
The report includes sections on raw-material suppliers, plant and machinery suppliers, process schemes, manufacturing operations, isolation and purification, plant layout, and project economics. Because pharmaceutical APIs require controlled manufacturing environments, project planning should also address material handling, process containment, analytical testing, documentation, waste management, worker safety, and the regulatory requirements applicable to the intended market.
The Indian ephedrine and API industry is influenced by healthcare demand, pharmaceutical consumption, imports, exports, manufacturing capabilities, and international market conditions.
The report examines the Indian pharmaceutical and API industry through market trade, domestic consumption, major APIs, import and export data, and the global market position of ephedrine. It also identifies opportunities involving international markets and OTC avenues, while discussing challenges such as dependence on external markets for intermediates and APIs, pricing and policy considerations, innovation capabilities, international quality scrutiny, and dependence on China for certain imports.
The report includes plant capacity, capital investment, working capital, rate of return, and break-even information.
The stated project figures include a plant capacity of 5.00 TON/day, Land & Building (3000 sq.mt.) of Rs. 4.00 Cr, Plant & Machinery of Rs. 3.09 Cr, Working Capital for 2 Months of Rs. 17.52 Cr, Total Capital Investment of Rs. 24.93 Cr, Rate of Return of 42%, and Break Even Point of 34%. The appendix further covers plant economics, fixed capital, raw materials, utilities, production costs, turnover, finance, depreciation, profit analysis, and a projected balance sheet.
Why Choose Us
- More than 45 years of experience
- Managed by expert industrial consultants
- ISO 9001-2015 Certified
- Registered under MSME, UAM No: DL01E0012000
How We Work
- 24/5 Research Support Get your queries resolved from an industry expert. Ask before you purchase.
- Custom Research Service Speak to our consultants to design an exclusive study for your needs.
- Quality Assurance All reports are prepared by qualified consultants & verified by experts.
- Information Security Your personal & confidential information is always safe and secure.
Detailed Project Report (DPR) includes Present Market Position and Expected Future Demand, Technology, Manufacturing Process, Investment Opportunity, Plant Economics and Project Financials. comprehensive analysis from industry covering detailed reporting and evaluates the position of the industry by providing insights to the SWOT analysis of the industry.
Each report include Plant Capacity, requirement of Land & Building, Plant & Machinery, Flow Sheet Diagram, Raw Materials detail with suppliers list, Total Capital Investment along with detailed calculation on Rate of Return, Break-Even Analysis and Profitability Analysis. The report also provides a birds eye view of the global industry with details on projected market size and then progresses to evaluate the industry in detail.
We can prepare detailed project report on any industry as per your requirement.
We can also modify the project capacity and project cost as per your requirement. If you are planning to start a business, contact us today.
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Key highlights
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge over major competitors
- An array of graphics, BEP analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth with an impact-analysis
- A clear understanding of the competitive landscape and key product segments
- Ask for FREE project related details with our consultant/industry expert.
- Share your specific research requirements for customized project report.
- Request for due diligence and consumer centric studies.
- Still haven't found what you're looking for? Speak to our Custom Research Team.
EIRI Board is a single destination for all the industry, company and country reports. We feature a large repository of latest industry reports, leading and niche company profiles, and market statistics prepared by highly qualified consultants and verified by a panel of experts.
Note: We can also prepare project report on any subject based on your requirement and country. If you need, we can modify the project capacity and project cost based on your requirement.
Our reports provide an expansive market analysis of the sector by covering areas like growth drivers, trends prevailing in the industry as well as comprehensive SWOT analysis of the sector.
Our Clients
- Our research reports comprehensively cover Indian markets (can be modified as per your country), present investigation, standpoint and gauge for a time of five years*.
- The market conjectures are produced on the premise of optional research and are cross-accepted through associations with the business players.
- We use dependable wellsprings of data and databases, and data from such sources is handled by us and incorporated into the report.
- Our project reports include detailed analysis that helps get the industry's Present Market Position and Expected Future Demand.
- Offer real analysis driving variables for the business and the most recent business sector patterns in the industry.
- This report comprehends the present status of the business by clarifying a complete SWOT examination and investigation of the interest-supply circumstance.
- Report gives analysis and in-depth financial comparison of real players/competitors.
- The report gives estimates of key parameters which forecast business execution.
